Procore Director’s Dual 10b5‑1 Trade: Buy the Dip While Balancing Liquidity – Insider Confidence Stays Strong Amid Valuation Woes

Insider Activity at Procore Technologies – What the Latest Deal Means for Investors

Recent Director Deal in Context On June 10, 2026, Craig F. Courtemanche Jr., a senior director, executed a buy transaction under a 10b5‑1 plan, adding 56,122 shares at the market price of $42.36. The trade was part of a broader pattern of plan‑based purchases that have kept his holdings steadily above 920,000 shares – roughly 14 % of outstanding equity. The timing coincides with a sharp decline in the stock (–12.8 % last week) and a negative sentiment score (+10) on social‑media chatter, suggesting that the trade may have been a “buy the dip” play rather than a sign of confidence in a short‑term rally.

What This Means for the Company’s Future Courtemanche’s consistent buying and relatively modest selling volumes signal a long‑term view, but the sheer size of the block sold on May 20–21 (12–15 k shares) shows that he is willing to liquidate when needed. The current purchase, coupled with the simultaneous “sell” of 56,000 shares by a different director under the same 10b5‑1 plan, indicates that the board is managing liquidity in a balanced way. For investors, the takeaway is that insider confidence remains strong, yet the stock’s negative earnings outlook (P/E –85.26) and 52‑week low of $41.70 suggest caution. The company’s focus on cloud‑based construction software positions it for long‑term growth, but the current valuation is heavily discounted.

Courtemanche’s Trading Profile Analyzing his history:

• Volume: Over the past six months he has bought about 300,000 shares and sold roughly 200,000, maintaining a net long position.
• Timing: Most purchases align with 10b5‑1 plan dates (December 2025, June 2026) and are executed at market prices that are below the 52‑week high by 50 %.
• Price Range: His selling prices have fluctuated from $47.37 to $73.21, while his buying prices have stayed near the low end of the band (around $2.42 or $45–50).
• Option Activity: He frequently sells stock‑options (right to buy) under the same plan, indicating a hedged strategy to lock in potential upside while preserving cash.

Overall, Courtemanche appears to be a disciplined long‑term holder who uses 10b5‑1 plans to mitigate timing risk.

Key Takeaways for Investors

• Insider confidence is intact: The director’s net long position and recent purchases suggest belief in the company’s long‑term trajectory.
• Liquidity is being managed: The simultaneous buy‑sell activity points to a deliberate, plan‑based approach rather than panic selling.
• Valuation concerns remain: With a P/E of –85.26 and a significant 52‑week low, the stock remains undervalued relative to its fundamentals.
• Watch for future plan expirations: Upcoming 10b5‑1 expirations in late 2026 could trigger more sales, potentially tightening the share supply and putting upward pressure on the price.

Bottom line: The latest insider transaction reinforces a narrative of patient ownership, but investors should keep an eye on the company’s valuation and upcoming plan expirations before committing new capital.